Omni Partners US’s FTAC Hera Acquisition Corp. Class A Ordinary Shares HERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.86M Sell
190,788
-6,407
-3% -$62.5K 0.1% 154
2021
Q2
$1.92M Buy
+197,195
New +$1.93M 0.08% 119

Other funds holding HERA

Omni Partners US's HERA Position: Q3 2021 in Review

Omni Partners US reduced its FTAC Hera Acquisition Corp. Class A Ordinary Shares (HERA) stake by 3.2% in Q3 2021, selling an estimated $62.5K and leaving 190,788 shares worth $1.86M. The position accounts for 0.1% of the portfolio, ranked #154.

Omni Partners US first reported a position in HERA in Q2 2021 and has held it in 2 quarters since. The position peaked at $1.92M in Q2 2021. 90 funds tracked by Wall St. Rank hold HERA as of Q3 2021.

  • Omni Partners US held 190,788 shares of FTAC Hera Acquisition Corp. Class A Ordinary Shares worth $1.86M as of Q3 2021.
  • Omni Partners US sold 6,407 FTAC Hera Acquisition Corp. Class A Ordinary Shares shares in Q3 2021, an estimated $62.5K.
  • FTAC Hera Acquisition Corp. Class A Ordinary Shares made up 0.1% of Omni Partners US's portfolio in Q3 2021, its #154 holding.
  • Omni Partners US first reported a position in FTAC Hera Acquisition Corp. Class A Ordinary Shares in Q2 2021 and has held it in 2 quarters since.
  • Omni Partners US's FTAC Hera Acquisition Corp. Class A Ordinary Shares position peaked at $1.92M in Q2 2021.
  • 90 funds tracked by Wall St. Rank held FTAC Hera Acquisition Corp. Class A Ordinary Shares as of Q3 2021.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.